Image
Image
Image

Press Release: SilkTech Biopharmaceuticals Completes Enrollment of Phase 2B Clinical Trial of SDP-4 for the Treatment of the Signs and Symptoms of Dry Eye Disease

Our latest Press Release! Phase 2B Clinical Trial

https://medicalalley.org/2019/08/silktech-biopharmaceuticals-completes-enrollment-of-phase-2b-clinical-trial-of-sdp-4-for-the-treatment-of-the-signs-and-symptoms-of-dry-eye-disease/

#dryeye #eyecare #ophthalmology #biopharmaceuticals #clinicaltrial

Navigation

  • About Us
  • Dry Eyes
  • News

Recent Media

  • SilkTech to Attend J.P. MORGAN 39TH ANNUAL HEALTHCARE CONFERENCE
  • SilkTech Accepted to the Spring 2021 Class of StartX
  • SilkTech Gives Interns the Freedom to Think for Themselves

  • Dry Eyes
  • About Us
    • Board of Directors
    • Management Team
    • Medical Advisory Board
  • News
  • About Us
  • Dry Eyes
  • News
Image

© SilkTech Biopharmaceuticals 2021 All Rights Reserved.

  • About Us
  • Dry Eyes
  • News
  • About Us
  • Dry Eyes
  • News
  • About Us
  • Dry Eyes
  • News